Factor V G1691A and prothrombin G20210A gene polymorphisms among Iranian patients with cerebral venous thrombosis

Neurology Asia

Volumn 17, Issue 3, 2012, Pages 199-203

  Ashjazadeh, Nahid ^a   Poursadeghfard, Maryam ^a   Farjadian, Shirin ^b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLELE; ARTICLE; CASE CONTROL STUDY; CEREBRAL SINUS THROMBOSIS; CONTROLLED STUDY; ETHNIC GROUP; FACTOR V LEIDEN GENE; FEMALE; GENE; GENE MUTATION; GENETIC POLYMORPHISM; HETEROZYGOSITY; HUMAN; IRAN; IRANIAN; MAJOR CLINICAL STUDY; MALE; MUTANT; NUCLEAR MAGNETIC RESONANCE IMAGING; PHLEBOGRAPHY; POLYMERASE CHAIN REACTION; PROTHROMBIN GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 84867273753     PISSN: 18236138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Bousser MG, Ferro JM. Cerebral venous thrombosis: an update. Lancet Neurol 2007; 6:162-70.
2. Bousser MG. Cerebral venous thrombosis: diagnosis and management. J Neurol 2000; 247:252-8.
3. Bergui M, Bradac GB. Clinical picture of patients with cerebral venous thrombosis and patterns of dural sinus involvement. Cerebrovasc Dis 2003; 16:211-6.
4. Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med 2005; 352:1791-8.
5. Ferro JM, Canhão P, Stam J, Bousser MG, Barinagarrementeria F; ISCVT Investigators. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 2004; 35:664-70.
6. De Stefano V, Rossi E, Paciaroni K, et al. Different circumstances of the first venouns thromboembolism among younger or older heterozygous carriers of the G20210A polymorphism in the prothrombin gene. Hematologica 2003; 88:61-6.
7. Martinelli I, Sacchi E, Landi G, Taioli E, Duca F, Mannucci PM. High risk cerebral-vein thrombosis in carriers of a prothrombin-geen mutation and in users of oral contraceptives. N Engl J Med 1998; 338:1793-7.
8. De Stefano V, Finazzi G, Mannucci PM. Inherited thrombophilia: pathogenesis, clinical syndromes, and manengment. Blood 1996; 87:3531-44.
9. Reuner KH, Ruf A, Grau A, et al. Prothrombin gene G20210->A transition is a risk factor for cerebral venous thrombosis. Stroke 1998; 29:1765-9.
10. Le Cam-Duchez V, Bagan-Triquenot A, Ménard JF, Mihout B, Borg JY. Association of the protein C promoter CG haplotype and the factor II G20210A mutation is a risk factor for cerebral venous thrombosis. Blood Coagul Fibrinolysis 2005; 16:495-500.
11. Gandrille S, Alhenc-Gelas M, Aiach M. A rapid screening method for the Factor V Leiden Arg 506 Gln mutation. Blood Coagul Fibrinolysis 1995; 6:245-8.
12. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88:3698-703.
13. Ashjazadeh N, Azin H. Investigation of clinical feature, etiologic and prognostic factors, radiologic and labroatony findings of cerebral venous sinus thrombosis between Jan 2000 to Aug 2003. Acta Nourol Taiwan 2008; 17:81-7.
14. Pashapoor A, Arami MA, Valavee A. Cerebral venous thrombosis in adult: A clinical study of 64 Iranian cases. IRCMJ 2009; 11:468-9.
15. Ashjazadeh N, Borhani Haghighi A, Poursadeghfard M, Azin H. Cerebral venous-sinus thrombosis: A case series analysis. IJMS 2011; 36:178-82.
16. Nagaraja D, Kruthika-Vinod TP, Christopher R. The prothrombin gene G20210A variant and puerperal cerebral venous and sinus thrombosis in south Indian women. J Clin Neurosci 2007; 14:635-8.
17. Awidi A, Shannak M, Bseiso A, et al. High prevalence of factor V Leiden in healthy Jordanian Arabs. Thromb Haemost 1999; 81:582-4.
18. Irani-Hakime N, Tamim H, Kreidy R, Almawi WY. The prevalence of factor V R506Q mutation Leiden among apparently healthy Lebanese. Am J Hematol 2000; 65:45-9.
19. Angchaisuksiri P, Pingsuthiwong S, Aryuchai K, et al. Prevalence of the G1691A mutation in the factor v gene (Factor V leiden) and the G20210A prothrombin gene mutation in the Thai population. Am J Hematol 2000; 65:119-22.
20. Zeinali S, Duca F, Zarbakhsh B, Tagliabue L, Mannucci PM. Thrombophilic mutations in Iran. Thromb Haemost 2000; 83:351-2.
21. Rahimi Z, Vaisi-Raygani A, Mozafari H, Kharrazi H, Rezaei M, Nagel RL. Prevalence of factor V Leiden (G1691A) and prothrombin (G20210A) among Kurdish population from Western Iran. J Thromb Thrombolysis 2008; 25:280-3.
22. Voetsch B, Damasceno BP, Camargo EC, et al. Inherited thrombophilia as a risk factor for the development of ischemic stroke in young adults. Thromb Haemost 2000; 83:229-33.
23. Bousser MG. An overview of cerebral venous thrombosis. J Watch Neurol 2005; 352:1791.
24. Dentali F, Crowther M, Ageno W. Thrombophilic abnormalities, oral contraceptives, and risk of cerebral vein thrombosis: a meta-analysis. Blood 2006; 107:2766-73.
25. Granel B, Morange PE, Serratrice J, et al. Heterozygous prothrombin gene mutation G20210A and associated diseases. Rev Med Interne 2003; 24:282-7.
26. Saadatnia M. Hormonal contraceptive as a risk factor for cerebral venous and sinus thrombosis. Acta Neurol Scand 2007; 115:295-300.
27. Altinisik J, Ates O, Ulutin T, Cengiz M, Buyru N. Factor v leiden, prothrombin G20210A, and protein C mutatins frequency in Turkish venous thrombosis patients. Clin Appl Thromb Hemost 2008; 14:415-20.
28. Bauduer F, Ducout L, Freyburger G. Assessment of the 20210G to A prothrombin variant in a sample of patients from the French Basque country with various thrombophilic conditions. Ann Hematol 2003; 82:353-6.
29. Rahimi Z, Mozafari H, Bigvand AH, et al. Cerebral venous and sinus thrombosis and thrombophilic mutations in Western Iran: association with factor V Leiden. Clin Appl Thromb Hemost 2010; 16:430-4.